Cargando…

The reasonable therapeutic modality for biliary duct-to-duct anastomotic stricture after liver transplantation: ERCP or PTC?

OBJECTIVE: To compare the initial success rate, feasibility, and effectiveness of endoscopic retrograde cholangiopancreatography (ERCP) versus percutaneous transhepatic cholangiography (PTC) for anastomotic biliary stricture after liver transplantation (LT). METHODS: We retrospectively analyzed the...

Descripción completa

Detalles Bibliográficos
Autores principales: Bowen, Hu, Wenzhi, Guo, Peihao, Wen, Jihua, Shi, Shuijun, Zhang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554635/
https://www.ncbi.nlm.nih.gov/pubmed/36249014
http://dx.doi.org/10.3389/fonc.2022.1035722
_version_ 1784806743207837696
author Bowen, Hu
Wenzhi, Guo
Peihao, Wen
Jihua, Shi
Shuijun, Zhang
author_facet Bowen, Hu
Wenzhi, Guo
Peihao, Wen
Jihua, Shi
Shuijun, Zhang
author_sort Bowen, Hu
collection PubMed
description OBJECTIVE: To compare the initial success rate, feasibility, and effectiveness of endoscopic retrograde cholangiopancreatography (ERCP) versus percutaneous transhepatic cholangiography (PTC) for anastomotic biliary stricture after liver transplantation (LT). METHODS: We retrospectively analyzed the data collected during January 2015 to December 2021 from liver transplantation recipients who developed anastomotic biliary stricture after liver transplantation and treated by ERCP and/or PTC. The success rate, complications and patients’ survival rate of ERCP and PTC procedures was evaluated. RESULTS: Forty-eight patients who underwent LT and were confirmed to have the anastomotic biliary stricture were enrolled. Overall, 48/48 patients underwent single or multiple ERCP procedures as the first line therapy; 121 therapeutic ERCPs (3.36 ± 2.53 ERCPs per patient) were performed in 36/48 patients successfully. All the 12 patients who failed ERCP tend to have special bile duct conditions such as overlong, angle shaped, and/or extremely narrowed bile duct and underwent PTC as an alternative treatment. The initial success rate of ERCP was 75% (36/48) while the success rate of ERCP for the 12 patients with special bile duct was 0% (0/12). PTC was an effective second-line treatment for those 12 patients who failed ERCP, and 58.33% (7 of 12 cases) were treated successfully. The average procedure time in PTC group was significantly lower than ERCP group (t=2.292, P=0.027). The feasibility of ERCP was associated with the anatomical shape of bile duct and the severity of the stricture site. Finally, the cumulative survival rate was 100% (12/12) in PTC group compared to 86.11% (31/36) in ERCP group (χ(2 =) 0.670, P=0.413). CONCLUSION: ERCP is the gold standard method for the diagnosis and effective intervention for the management of biliary complications after LT. However, its use in certain types of biliary complications (e.g., patients with severe anastomotic biliary stricture and those with overlong and angle shaped bile ducts) is not promising and associated with significant risk of complications. PTC and other interventions should be studied along with ERCP for patients for whom ERCP may not work. The feasibility and efficacy of primary management can be predicted by the noninvasive imaging examinations like Magnetic Resonance Cholangiopancreatography (MRCP) before the procedure, which may help with the choice of the most reasonable therapeutic modality and avoiding unnecessary financial burden and complications.
format Online
Article
Text
id pubmed-9554635
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95546352022-10-13 The reasonable therapeutic modality for biliary duct-to-duct anastomotic stricture after liver transplantation: ERCP or PTC? Bowen, Hu Wenzhi, Guo Peihao, Wen Jihua, Shi Shuijun, Zhang Front Oncol Oncology OBJECTIVE: To compare the initial success rate, feasibility, and effectiveness of endoscopic retrograde cholangiopancreatography (ERCP) versus percutaneous transhepatic cholangiography (PTC) for anastomotic biliary stricture after liver transplantation (LT). METHODS: We retrospectively analyzed the data collected during January 2015 to December 2021 from liver transplantation recipients who developed anastomotic biliary stricture after liver transplantation and treated by ERCP and/or PTC. The success rate, complications and patients’ survival rate of ERCP and PTC procedures was evaluated. RESULTS: Forty-eight patients who underwent LT and were confirmed to have the anastomotic biliary stricture were enrolled. Overall, 48/48 patients underwent single or multiple ERCP procedures as the first line therapy; 121 therapeutic ERCPs (3.36 ± 2.53 ERCPs per patient) were performed in 36/48 patients successfully. All the 12 patients who failed ERCP tend to have special bile duct conditions such as overlong, angle shaped, and/or extremely narrowed bile duct and underwent PTC as an alternative treatment. The initial success rate of ERCP was 75% (36/48) while the success rate of ERCP for the 12 patients with special bile duct was 0% (0/12). PTC was an effective second-line treatment for those 12 patients who failed ERCP, and 58.33% (7 of 12 cases) were treated successfully. The average procedure time in PTC group was significantly lower than ERCP group (t=2.292, P=0.027). The feasibility of ERCP was associated with the anatomical shape of bile duct and the severity of the stricture site. Finally, the cumulative survival rate was 100% (12/12) in PTC group compared to 86.11% (31/36) in ERCP group (χ(2 =) 0.670, P=0.413). CONCLUSION: ERCP is the gold standard method for the diagnosis and effective intervention for the management of biliary complications after LT. However, its use in certain types of biliary complications (e.g., patients with severe anastomotic biliary stricture and those with overlong and angle shaped bile ducts) is not promising and associated with significant risk of complications. PTC and other interventions should be studied along with ERCP for patients for whom ERCP may not work. The feasibility and efficacy of primary management can be predicted by the noninvasive imaging examinations like Magnetic Resonance Cholangiopancreatography (MRCP) before the procedure, which may help with the choice of the most reasonable therapeutic modality and avoiding unnecessary financial burden and complications. Frontiers Media S.A. 2022-09-29 /pmc/articles/PMC9554635/ /pubmed/36249014 http://dx.doi.org/10.3389/fonc.2022.1035722 Text en Copyright © 2022 Bowen, Wenzhi, Peihao, Jihua and Shuijun https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Bowen, Hu
Wenzhi, Guo
Peihao, Wen
Jihua, Shi
Shuijun, Zhang
The reasonable therapeutic modality for biliary duct-to-duct anastomotic stricture after liver transplantation: ERCP or PTC?
title The reasonable therapeutic modality for biliary duct-to-duct anastomotic stricture after liver transplantation: ERCP or PTC?
title_full The reasonable therapeutic modality for biliary duct-to-duct anastomotic stricture after liver transplantation: ERCP or PTC?
title_fullStr The reasonable therapeutic modality for biliary duct-to-duct anastomotic stricture after liver transplantation: ERCP or PTC?
title_full_unstemmed The reasonable therapeutic modality for biliary duct-to-duct anastomotic stricture after liver transplantation: ERCP or PTC?
title_short The reasonable therapeutic modality for biliary duct-to-duct anastomotic stricture after liver transplantation: ERCP or PTC?
title_sort reasonable therapeutic modality for biliary duct-to-duct anastomotic stricture after liver transplantation: ercp or ptc?
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554635/
https://www.ncbi.nlm.nih.gov/pubmed/36249014
http://dx.doi.org/10.3389/fonc.2022.1035722
work_keys_str_mv AT bowenhu thereasonabletherapeuticmodalityforbiliaryducttoductanastomoticstrictureafterlivertransplantationercporptc
AT wenzhiguo thereasonabletherapeuticmodalityforbiliaryducttoductanastomoticstrictureafterlivertransplantationercporptc
AT peihaowen thereasonabletherapeuticmodalityforbiliaryducttoductanastomoticstrictureafterlivertransplantationercporptc
AT jihuashi thereasonabletherapeuticmodalityforbiliaryducttoductanastomoticstrictureafterlivertransplantationercporptc
AT shuijunzhang thereasonabletherapeuticmodalityforbiliaryducttoductanastomoticstrictureafterlivertransplantationercporptc
AT bowenhu reasonabletherapeuticmodalityforbiliaryducttoductanastomoticstrictureafterlivertransplantationercporptc
AT wenzhiguo reasonabletherapeuticmodalityforbiliaryducttoductanastomoticstrictureafterlivertransplantationercporptc
AT peihaowen reasonabletherapeuticmodalityforbiliaryducttoductanastomoticstrictureafterlivertransplantationercporptc
AT jihuashi reasonabletherapeuticmodalityforbiliaryducttoductanastomoticstrictureafterlivertransplantationercporptc
AT shuijunzhang reasonabletherapeuticmodalityforbiliaryducttoductanastomoticstrictureafterlivertransplantationercporptc